title: De novo onset of arthritis in patients previously treated with efalizumab: an observational case series.
authors.forename: Matteo
authors.initials: M
authors.lastname: Colina
authors.forename: Giovanni
authors.initials: G
authors.lastname: Cianco
authors.forename: Micheline
authors.initials: M
authors.lastname: Khodeir
authors.forename: Stella
authors.initials: S
authors.lastname: Sferra
authors.forename: Paola
authors.initials: P
authors.lastname: Scanavacca
authors.forename: Monica
authors.initials: M
authors.lastname: Corazza
authors.forename: Anna
authors.initials: A
authors.lastname: Virgili
authors.forename: Francesco
authors.initials: F
authors.lastname: Trotta
mesh_terms: D000287:Administration, Topical; D000293:Adolescent; D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D015535:Arthritis, Psoriatic / Q000150:complications / Q000209:etiology* / Q000473:pathology; D003879:Dermatologic Agents / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007596:Joints / Q000187:drug effects / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D057051:Product Recalls and Withdrawals; D011565:Psoriasis / Q000188:drug therapy*; D028761:Withholding Treatment
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D003879:Dermatologic Agents; C472181:efalizumab